Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 3, 2013, Pages 183-187

  Mostowska, Adrianna ^a   Sajdak, Stefan ^a   Pawlik, Piotr ^a   Lianeri, Margarita ^a   Jagodzinski, Pawel P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CARCINOGENESIS; DNA POLYMORPHISM; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; POLYMERASE CHAIN REACTION; RECESSIVE INHERITANCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OVARIAN NEOPLASMS; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 84874336262     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0332     Document Type: Article

References (41)

1. Arai H, Miyamoto K-I, Taketani Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japan women. J Bone Miner Res 12: 915-921. (Pubitemid 27225001)
2. Arjumand W, Ahmad ST, Seth A, et al. (2012) Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol 33:23-31.
3. Bai Y, Yu Y, Yu B, et al. (2009) Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med Genet 10:125.
4. Bai YH, Lu H, Hong D, et al. (2012) Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic metaanalysis. World J Gastroenterol 18:1672-1679.
5. Bakhru A, Mallinger JB, Buckanovich RJ, et al. (2010) Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES. Gynecol Oncol 119:314-318.
6. Brekelmans CT (2003) Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol 15:63-68. (Pubitemid 36143495)
7. Cheng TY, Neuhouser ML (2012) Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction. Cancer Causes Control 23:1557-1565.
8. Churilla TM, Brereton HD, Klem M, et al. (2012) Vitamin D deficiency is widespread in cancer patients and correlates with advanced stage disease: a community oncology experience. Nutr Cancer 64:521-525.
9. Clendenen TV, Arslan AA, Koenig KL, et al. (2008) Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett 260:209-215.
10. Falleti E, Bitetto D, Fabris C, et al. (2010) Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol 16:3016-3024.
11. Gandini S, Raimondi S, Gnagnarella P, et al. (2009) Vitamin D and skin cancer: a meta-analysis. Eur J Cancer 45:634-641.
12. Grant WB (2012) Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res 32:223-236.
13. Imtiaz S, Siddiqui N, Raza SA, et al. (2012) Vitamin D deficiency in newly diagnosed breast cancer patients. Indian J Endocrinol Metab 16:409-413.
14. Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61:69-90.
15. Ko? stner K, Denzer N, Mu? ller CS, et al. (2009) The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res 29:3511-3536.
16. Liu Z, Calderon JI, Zhang Z, et al. (2005) Polymorphisms of vitamin D receptor gene protect against the risk of head and neck cancer. Pharmacogenet Genomics 15:159-165. (Pubitemid 40569902)
17. Luo XY, Yang MH, Wu FX, et al. (2012) Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population. Lupus 21:53-59.
18. Lurie G, Wilkens LR, Thompson PJ, et al. (2007) Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 16:2566-2571. (Pubitemid 351196310)
19. Lurie G, Wilkens LR, Thompson PJ, et al. (2011) Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium. Int J Cancer 128:936-943.
20. Ma Y, Yu WD, Su B, et al. (2012) Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1a,25- dihydroxycholecalciferol. Cancer 2012 [Epub ahead of print]; DOI: 10.1002/cncr.27531.
21. Maruotti N, Cantatore FP (2010) Vitamin D and the immune system. J Rheumatol 37:491-495.
22. Merritt MA, Cramer DW, Vitonis AF, et al. (2012) Dairy foods and nutrients in relation to risk of ovarian cancer and major histological subtypes. Int J Cancer [Epub ahead of print]; DOI: 10.1002/ijc.27701.
23. Mishra DK, Bid HK, Srivastava DS, et al. (2005) Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India. Urol Int 74:315-318. (Pubitemid 40864154)
24. Mittal RD, Manchanda PK, Bhat S, et al. (2007) Association of vitamin-D receptor (Fok-I) gene polymorphism with bladder cancer in an Indian population. BJU Int 99:933-937. (Pubitemid 46439554)
25. Miyamoto K, Kesterson RA, Yamamoto H, et al. (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocr 11:1165-1179. (Pubitemid 27278838)
26. Monticielo OA, Brenol JC, Chies JA, et al. (2012) The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus 21:43-52.
27. Orell-Kotikangas H, Schwab U, Osterlund P, et al. (2012) High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck 34:1450-1455.
28. Penna-Martinez M, Ramos-Lopez E, Stern J, et al. (2009) Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid 19:623-628.
29. Pereira F, Larriba MJ, Mun? oz A (2012) Vitamin D and colon cancer. Endocr Relat Cancer 19:R51-R71.
30. Ren C, Qiu MZ, Wang DS, et al. (2012) Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer. Carcinogenesis 33:1319-1326.
31. Romero I, Bast RC Jr. (2012) Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology 153:1593-1602.
32. Roskies M, Dolev Y, Caglar D, et al. (2012) Vitamin d deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg 41:160-163.
33. Sueblinvong T, Carney ME (2009) Current understanding of risk factors for ovarian cancer. Curr Treat Options Oncol 10:67-81.
34. Swami S, Krishnan AV, Wang JY, et al. (2012) Dietary vitamin D3 and 1,25-dihydroxyvitamin D3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology 153:2576-2587.
35. Tamez S, Norizoe C, Ochiai K, et al. (2009) Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br J Cancer 101:1957-1960.
36. Tang C, Chen N, Wu M, et al. (2009) Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 117:391-399.
37. Tworoger SS, Gates MA, Lee IM, et al. (2009) Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies. Cancer Res 69:1885-1891.
38. Uitterlinden AG, Fang Y, Van Meurs JBJ, et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143-156. (Pubitemid 39094759)
39. Wolden-Kirk H, Gysemans C, Verstuyf A, et al. (2012) Extraskeletal effects of vitamin D. Endocrinol Metab Clin North Am 41:571-594.
40. Zhang J, Chalmers MJ, Stayrook KR, et al. (2011) DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol 18:556-563.
41. Zhang X, Nicosia SV, Bai W (2006) Vitamin D receptor is a novel drug target for ovarian cancer treatment. Curr Cancer Drug Targets 6:229-244. (Pubitemid 43764742)